Panacea Index Logo

Command Palette

Search for a command to run...

Exoskeleton-Assisted Walking for Pulmonary and Exercise Performances of SCI Individuals.

IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society
January 1, 2023
Xiao-Na Xiang et al. (10 authors)
Randomized Controlled TrialJournal ArticleResearch Support, Non-U.S. Gov'tHuman StudyClinical
Study Details

Study Goal

To determine if exoskeleton-assisted walking (EAW) improves pulmonary ventilation, motor function, and daily activities as effectively as conventional exercise in people with spinal cord injury (SCI).

Results Summary

EAW improved forced vital capacity, predicted FVC%, forced expiratory volume, basic activities of daily living, and distal femoral cartilage more than conventional exercise. No differences were found in trunk/lower extremity motor function, bone mineral density, or adverse events.

Population

40 participants (7 females, 33 males; age 37.1±12.0 years) with thoracic SCI.

Effective Dosage

16 sessions of 50-60 min training (4 days/week).

Duration

4 weeks (16 sessions).

Interactions

None mentioned.

Extracted Claims (13)
InterventionDirectionEndpointPopulationDosageImpactClaim #
exoskeleton-assisted walking (EAW) training
increase
forced vital capacity (FVC)
people with spinal cord injury (SCI)
0.53 L [0.01-1.06 L]
improved more than the control group
#1
exoskeleton-assisted walking (EAW) training
increase
predicted FVC%
people with spinal cord injury (SCI)
19.59 [6.63-32.54]
improved more than the control group
#2
exoskeleton-assisted walking (EAW) training
increase
forced expiratory volume in 1s
people with spinal cord injury (SCI)
0.61 L [0.15-1.07 L]
improved more than the control group
#3
exoskeleton-assisted walking (EAW) training
increase
basic activities of daily living (BADL)
people with spinal cord injury (SCI)
19.75 [10.88-28.62]
improved more than the control group
#4
exoskeleton-assisted walking (EAW) training
increase
distal femoral cartilage
people with spinal cord injury (SCI)
-
improved more than the control group
#5
exoskeleton-assisted walking (EAW) training
neutral
6-minute walk test
people with spinal cord injury (SCI)
median 17.3 meters
completed
#6
exoskeleton-assisted walking (EAW) training
no change
trunk and lower extremity motor function
people with spinal cord injury (SCI)
-
no difference
#7
exoskeleton-assisted walking (EAW) training
no change
bone mineral density
people with spinal cord injury (SCI)
-
no difference
#8
exoskeleton-assisted walking (EAW) training
no change
adverse events
people with spinal cord injury (SCI)
-
no difference
#9
exoskeleton-assisted walking (EAW) training
increase
pulmonary ventilation function
people with lower thoracic neurological level of SCI
-
has potential benefits to facilitate
#10
exoskeleton-assisted walking (EAW) training
increase
walking
people with lower thoracic neurological level of SCI
-
has potential benefits to facilitate
#11
exoskeleton-assisted walking (EAW) training
increase
BADL
people with lower thoracic neurological level of SCI
-
has potential benefits to facilitate
#12
exoskeleton-assisted walking (EAW) training
increase
thickness of cartilage
people with lower thoracic neurological level of SCI
-
has potential benefits to facilitate
#13
Abstract

OBJECTIVE: To determine whether exoskeleton-assisted walking (EAW) improves pulmonary ventilation function, motor function and related body structure, and activities equivalently as the conventional exercise program for people with spinal cord injury (SCI). METHODS: Forty participants (7 females and 33 males; age 37.1±12.0 years) with thoracic SCI were randomized into two groups and undertook 16 sessions of 50-60 min training (4 days/week). Participants in the EAW group received EAW trainings, such as assisted standing, walking, and climbing the stairs. The control group received a conventional exercise program. Outcomes were measured at baseline and upon completion of treatment. RESULTS: After trainings, the EAW group improved more than the control group in the forced vital capacity (FVC, 0.53 L [0.01-1.06 L]), predicted FVC% (19.59 [6.63-32.54]) and forced expiratory volume in 1s (0.61 L [0.15-1.07 L]), basic activities of daily living (BADL) (19.75 [10.88-28.62]), and distal femoral cartilage. Participants in the EAW group completed 6-minute walk test with median 17.3 meters while wearing the exoskeleton. There was no difference in trunk and lower extremity motor function, bone mineral density, and adverse events ( P > 0.05). CONCLUSION: In people with lower thoracic neurological level of SCI, EAW training has potential benefits to facilitate pulmonary ventilation function, walking, BADL and thickness of cartilage comparing to a conventional excise program. SIGNIFICANCE: This study provided more evidence for using EAW in clinic, and partly proved EAW had equivalent effects as conventional exercise program, which may combine with conventional exercise program for reducing burden of therapists in the future.

Medical Subject Headings (MeSH)
MaleFemaleHumansAdultMiddle AgedExoskeleton DeviceActivities of Daily LivingSpinal Cord InjuriesWalkingExercise
Study Links
Quality Scores
Safety85
Efficacy75/10
Quality80/10
Citation Metrics
Total Citations1
Citations/Year0.5
Relative Citation Ratio0.67
NIH Percentile35.9%
Research Impact Scores
APT Score0.25
Weight Score2.43
Normalized Score0.80
Related Supplements
Exoskeleton-Assisted Walking for Pulmonary and Exercise Perf... | Panacea Index